
Keywords: AIs; aromatase inhibitors; AMPK; Adenosine Monophosphate-Activated Protein Kinase; AR; androgen; ATM; Ataxia Telangiectasia Mutated; ATP; Adenosine Triphosphate; BCSS; breast cancer specific survival; CK-MB; Creatine Kinase-MB; CREB1; cAMP Response Elemen